Rede Wealth, LLC - ADIAL PHARMACEUTICALS INC ownership

ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 19 filers reported holding ADIAL PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Rede Wealth, LLC ownership history of ADIAL PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$41,000
-36.9%
15,2000.0%0.02%
-40.0%
Q3 2021$65,000
+66.7%
15,2000.0%0.04%
+66.7%
Q2 2021$39,000
+8.3%
15,200
+1.3%
0.02%0.0%
Q1 2021$36,00015,0000.02%
Other shareholders
ADIAL PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,817,454$3,653,0000.07%
CSS LLC/IL 41,300$83,0000.00%
Empirical Financial Services, LLC d.b.a. Empirical Wealth Management 35,000$70,0000.00%
CSS LLC/IL 33,900$68,0000.00%
Private Advisor Group, LLC 34,150$69,0000.00%
OPPENHEIMER & CO INC 38,500$77,0000.00%
High Net Worth Advisory Group LLC 1,000$2,0000.00%
VANGUARD GROUP INC 590,852$1,187,0000.00%
UBS Group AG 6,840$14,0000.00%
OSAIC HOLDINGS, INC. 8,321$25,0000.00%
View complete list of ADIAL PHARMACEUTICALS INC shareholders